Refractory Digital Ulcers Treated by Botulinum Toxin and Endothelin Receptor-1 Antagonist in Anti-MDA5-Antibody-Positive Dermatomyositis

Hong-Ki MIN; Hae-Rim KIM; Sang-Heon LEE; Sung-Hye PARK; Jeeyoung OH; Kyomin CHOI; Hong-Ki MIN; Hae-Rim KIM; Sang-Heon LEE; Sung-Hye PARK; Jeeyoung OH; Kyomin CHOI.
Journal of Clinical Neurology ; : 160-162, 2020.
Artículo en Inglés | WPRIM | ID: wpr-782060

Documentos relacionados

  1. Undermining Ulcers in Juvenile Dermatomyositis.
  2. "Qui la voce sua soave": "Maria Callas' dermatomyositis"-art beyond disease and its stigma.
  3. Linear juvenile dermatomyositis: A segmental manifestation.
  4. Early-onset juvenile dermatomyositis: A report of two cases and review of the literature.
  5. Clinical heterogeneities and prognoses of patients with myositis specific antibody negative dermatomyositis: a retrospective study in China.
  6. A case series of hydroxychloroquine exacerbating the dermatomyositis rash.
  7. Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study.
  8. Wong-type dermatomyositis.
  9. Serum levels of lysyl oxidase-like 2 are increased in patients with dermatomyositis.
  10. Clinical Presentation and Evaluation of Dermatomyositis.